Creatinyl amino acids—new hybrid compounds with neuroprotective activity
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Prolonged oral creatine administration resulted in remarkable neuroprotection in experimental models of brain stroke. However, because of its polar nature creatine has poor ability to penetrate the blood–brain barrier (BBB) without specific creatine transporter (CRT). Thus, synthesis of hydrophobic derivatives capable of crossing the BBB by alternative pathway is of great importance for the treatment of acute and chronic neurological diseases including stroke, traumatic brain injury and hereditary CRT deficiency. Here we describe synthesis of new hybrid compounds—creatinyl amino acids, their neuroprotective activity in vivo and stability to degradation in different media. The title compounds were synthesized by guanidinylation of corresponding sarcosyl peptides or direct creatine attachment using isobutyl chloroformate method. Addition of lipophilic counterion (p‐toluenesulfonate) ensures efficient creatine dissolution in DMF with simultaneous protection of guanidino group towards intramolecular cyclization. It excludes the application of expensive guanidinylating reagents, permits to simplify synthetic procedure and adapt it to large‐scale production. The biological activity of creatinyl amino acids was tested in vivo on ischemic stroke and NaNO 2‐induced hypoxia models. One of the most effective compounds—creatinyl‐glycine ethyl ester increases life span of experimental animals more than two times in hypoxia model and has neuroprotective action in brain stroke model when applied both before and after ischemia. These data evidenced that creatinyl amino acids can represent promising candidates for the development of new drugs useful in stroke treatment. Copyright © 2011 European Peptide Society and John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Experimental studies of ischemic brain edema
Koizumi, J.-I., Yoshida, Y., Nakazawa, T., & Ooneda, G. (1986) · Nosotchu · doi:10.3995/jstroke.8.1 · Cited by 996
Prophylactic Creatine Administration Mediates Neuroprotection in Cerebral Ischemia in Mice
Zhu, S., Li, M., Figueroa, B. E., Liu, A., Stavrovskaya, I. G., Pasinelli, P., Beal, M. F., Brown, R. H., Kristal, B. S., Ferrante, R. J., et al. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1278-04.2004 · Cited by 138
Improved Reperfusion and Neuroprotection by Creatine in a Mouse Model of Stroke
Prass, K., Royl, G., Lindauer, U., Freyer, D., Megow, D., Dirnagl, U., Stöckler-Ipsiroglu, G., Wallimann, T., & Priller, J. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600351 · Cited by 128
Non-enzymatic cyclization of creatine ethyl ester to creatinine
Giese, M. W., & Lecher, C. S. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.07.151 · Cited by 27
Cited by
Precision Nanomedicine in Neurodegenerative Diseases
Goldsmith, M., Abramovitz, L., & Peer, D. (2014) · ACS Nano · doi:10.1021/nn501292z · Cited by 124
“ESBA105 was detected at significantly higher levels following IN administration, as compared to the levels after IV delivery.36 These examples validate that the IN administration route may serve as an advantageous approach for the treatment of NDs. Nanotechnology-Based Drug-Delivery Strategies.”
BackgroundInfluentialCreatine and guanidinoacetate transport at blood-brain and blood-cerebrospinal fluid barriers
Braissant, O. (2012) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-011-9433-2 · Cited by 112
“More interestingly, PCr-Mg-complex acetate and the very recently described creatinyl amino acids showed neuroprotective effects in vivo in rodents, thus suggesting a crossing of BBB (Burov et al. 2011; Perasso et al. 2009).”
BackgroundHanna-El-Daher, L., & Braissant, O. (2016) · Amino Acids · doi:10.1007/s00726-016-2189-0 · Cited by 65
Trotier-Faurion, A., Dézard, S., Taran, F., Valayannopoulos, V., de Lonlay, P., & Mabondzo, A. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400545n · Cited by 36
Metadata
- Authors
- Burov, S., Leko, M., Dorosh, M., Dobrodumov, A., & Veselkina, O.
- Venue
- Journal of Peptide Science
- Publisher
- Wiley
- Published
- 2011-06-06
- Volume
- 17
- Issue
- 9
- Pages
- 620-626
- ISSN
- 1075-2617 (ISSN-L)
- 1099-1387
- OpenAlex
- W2058116726
- Cited by
- 24
- References
- 4
- FWCI
- 1.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Creatinyl amino acids—new hybrid compounds with neuroprotective activity. https://app.cochat.ai/papers/10.1002/psc.1379
- The paper
- Burov, S., Leko, M., Dorosh, M., Dobrodumov, A., & Veselkina, O. (2011). Creatinyl amino acids—new hybrid compounds with neuroprotective activity. Journal of Peptide Science. https://doi.org/10.1002/psc.1379
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.